These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34773568)

  • 1. Safety and efficacy of cerebral embolic protection devices in patients undergoing transcatheter aortic valve replacement: a meta-analysis of in-hospital outcomes.
    Shimamura J; Kuno T; Malik A; Yokoyama Y; Gupta R; Ahmad H; Briasoulis A
    Cardiovasc Interv Ther; 2022 Jul; 37(3):549-557. PubMed ID: 34773568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral embolic protection during transcatheter aortic valve replacement: a systematic review and meta-analysis of propensity score matched and randomized controlled trials using the Sentinel cerebral embolic protection device.
    Wolfrum M; Handerer IJ; Moccetti F; Schmeisser A; Braun-Dullaeus RC; Toggweiler S
    BMC Cardiovasc Disord; 2023 Jun; 23(1):306. PubMed ID: 37330463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.
    Seeger J; Gonska B; Otto M; Rottbauer W; Wöhrle J
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2297-2303. PubMed ID: 28917515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral Protection During Transcatheter Aortic Valve Implantation: An Updated Systematic Review and Meta-Analysis.
    Testa L; Latib A; Casenghi M; Gorla R; Colombo A; Bedogni F
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes of Sentinel Cerebral Protection System Use During Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.
    Ndunda PM; Vindhyal MR; Muutu TM; Fanari Z
    Cardiovasc Revasc Med; 2020 Jun; 21(6):717-722. PubMed ID: 31175048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral Embolic Protection and Outcomes of Transcatheter Aortic Valve Replacement: Results From the Transcatheter Valve Therapy Registry.
    Butala NM; Makkar R; Secemsky EA; Gallup D; Marquis-Gravel G; Kosinski AS; Vemulapalli S; Valle JA; Bradley SM; Chakravarty T; Yeh RW; Cohen DJ
    Circulation; 2021 Jun; 143(23):2229-2240. PubMed ID: 33619968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Cerebral Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: An Updated Meta-Analysis.
    Kaur A; Dhaliwal AS; Sohal S; Gwon Y; Gupta S; Bhatia K; Dominguez AC; Basman C; Tamis-Holland J
    J Am Heart Assoc; 2024 Feb; 13(3):e030587. PubMed ID: 38240252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological Outcomes With Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Giustino G; Mehran R; Veltkamp R; Faggioni M; Baber U; Dangas GD
    JACC Cardiovasc Interv; 2016 Oct; 9(20):2124-2133. PubMed ID: 27765306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral embolic protection systems for transcatheter aortic valve replacement.
    Gasior T; Mangner N; Bijoch J; Wojakowski W
    J Interv Cardiol; 2018 Dec; 31(6):891-898. PubMed ID: 30467892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis.
    Seeger J; Kapadia SR; Kodali S; Linke A; Wöhrle J; Haussig S; Makkar R; Mehran R; Rottbauer W; Leon M
    Eur Heart J; 2019 May; 40(17):1334-1340. PubMed ID: 30590554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement.
    Kapadia SR; Makkar R; Leon M; Abdel-Wahab M; Waggoner T; Massberg S; Rottbauer W; Horr S; Sondergaard L; Karha J; Gooley R; Satler L; Stoler RC; Messé SR; Baron SJ; Seeger J; Kodali S; Krishnaswamy A; Thourani VH; Harrington K; Pocock S; Modolo R; Allocco DJ; Meredith IT; Linke A;
    N Engl J Med; 2022 Oct; 387(14):1253-1263. PubMed ID: 36121045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Implantation: Systematic Review and Meta-Analysis.
    Bagur R; Solo K; Alghofaili S; Nombela-Franco L; Kwok CS; Hayman S; Siemieniuk RA; Foroutan F; Spencer FA; Vandvik PO; Schäufele TG; Mamas MA
    Stroke; 2017 May; 48(5):1306-1315. PubMed ID: 28411259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a Two-Filter Cerebral Embolic Protection Device on the Complexity and Risk of Transcatheter Aortic Valve Replacement.
    Voss S; Deutsch MA; Schechtl J; Erlebach M; Sideris K; Lange R; Bleiziffer S
    Thorac Cardiovasc Surg; 2020 Oct; 68(7):616-622. PubMed ID: 31091551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Cerebral Embolic Protection for Bicuspid Aortic Valve Stenosis Undergoing Transcatheter Aortic Valve Replacement.
    Zhang J; Li X; Tian R; Zong M; Gu X; Xu F; Chen Y; Li C
    J Am Heart Assoc; 2023 Jun; 12(12):e028890. PubMed ID: 37301750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcome of Transcatheter Aortic Valve Replacement With TriGUARD 3™ Cerebral Embolic Protection Device.
    Daal SM; Jimenez-Rodriguez GMJ; Voskuil M; Kraaijeveld AO; Dessing TC; Ramjankhan FZ; Mokhles MM; Stella PR
    Cardiovasc Revasc Med; 2023 May; 50():8-12. PubMed ID: 36681530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection from Cerebral Embolic Events During Transcatheter Aortic Valve Replacement.
    Rossow CF; McCabe JM
    Curr Cardiol Rep; 2016 Feb; 18(2):16. PubMed ID: 26768742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcarotid transcatheter aortic valve replacement with cerebral embolic protection.
    McGrath D; Salehi P; Weintraub A; Zhan Y
    J Card Surg; 2022 Jun; 37(6):1779-1782. PubMed ID: 35301761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral embolic protection and severity of stroke following transcatheter aortic valve replacement.
    Isogai T; Vanguru HR; Krishnaswamy A; Agrawal A; Spilias N; Shekhar S; Saad AM; Verma BR; Puri R; Reed GW; Popović ZB; Unai S; Yun JJ; Uchino K; Kapadia SR
    Catheter Cardiovasc Interv; 2022 Nov; 100(5):810-820. PubMed ID: 35916117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cerebral protection on observed versus predicted in-hospital stroke in a high stroke risk TAVR cohort.
    Marcusohn E; Manoragavan R; Fremes S; Tarola C; Sathananthan J; Barabash IM; Orbach A; Sachedina AK; Radhakrishnan S; Wijeysundera HC
    BMC Cardiovasc Disord; 2024 Aug; 24(1):422. PubMed ID: 39135174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embolic protection in patients undergoing transaortic transcatheter aortic valve replacement: initial experience with the TriGuard HDH embolic deflection device.
    Campelo-Parada F; Regueiro A; Dumont E; DeLarochellière R; Paradis JM; Mohammadi S; Doyle D; Rodés-Cabau J
    J Card Surg; 2016 Oct; 31(10):617-622. PubMed ID: 27577965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.